Sustained low‐density lipoprotein‐cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting-Reference-Cited by-同舟云学术

Sustained low‐density lipoprotein‐cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting

Published:2021-12-21 Issue: Volume: Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Sánchez‐Bacaicoa Carmen¹,Galán Javier²,Guijarro Carlos³^ORCID,Rico‐Martín Sergio⁴^ORCID,Monreal Manuel⁵,Calderón‐García Julián F.⁴,Aguilar‐Cortés Eduardo⁶,Sánchez Muñoz‐Torrero Juan F.²,Alcalá‐Pedrajas JN,Alvarez LR,Arnedo G,Coll R,García‐Díaz A,López‐Jiménez L,Pascual MT,Sahuquillo JC,Sanclemente C,Suriñach JM,Toril J,Yeste M,

Affiliation:

1. Department of Family Medicine Hospital of Menorca Menorca Spain

2. Department of Internal Medicine Hospital San Pedro Alcántara Cáceres Spain

3. Department of Medical Specialties and Public Heatlh Alcorcon University Hospital. Rey Juan Carlos University Madrid Spain

4. Department of Nursing, Nursing and Occupational Therapy College University of Extremadura Cáceres Spain

5. Department of Internal Medicine Hospital Germans Trias i Pujol Badalona Spain

6. Department of Internal Medicine Hospital de Alcañiz Teruel Spain

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13732

Reference42 articles.

1. Heart disease and stroke statistics‐2016 update: a report from the American Heart Association;Mozaffarian D;Circulation,2016

2. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering

3. Long-Term Benefit of Statin Therapy Initiated??during Hospitalization for??an??Acute??Coronary Syndrome

4. Reaching low‐density lipoprotein cholesterol treatment targets in stable coronary artery disease: determinants and prognostic impact;Bauters C;Arch Cardiovasc Dis,2018

5. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From remnant cholesterol to lipoprotein(a) – emerging risk factors for cardiovascular diseases beyond low density lipoprotein;Current Opinion in Cardiology;2024-06-06

2. Proprotein convertase subtilisin/kexin 9 inhibitor downregulates microRNA-130a-3p expression in hepatocytes to alleviates atherosclerosis progression;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-15

3. Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids;Current Opinion in Cardiology;2023-07

4. Optimal Control of all Modifiable Vascular Risk Factors Among Patients With Atherosclerotic Disease. A Real-Life Study;Current Problems in Cardiology;2023-03

5. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID‐REAL registry;European Journal of Clinical Investigation;2022-09-05